Navigation Links
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
Date:11/21/2007

LAVAL, QC, Nov. 21 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has received a written response from the U.S. Food and Drug Administration (FDA) regarding its appeal of the Agency's Approvable Letter for its once-daily tramadol formulation through the Formal Dispute Resolution process. In the response, the Acting Director of the Office of Drug Evaluation II, Center for Drug Evaluation and Research has not overturned the decision in the Agency's Approvable Letter of May 2007.

Labopharm plans to appeal the matter to the next supervisory level at the FDA in the coming weeks.

Labopharm initiated the Formal Dispute Resolution process in October of this year after receiving an Approvable Letter from the FDA for its once-daily formulation of tramadol in May.

About the FDA's Formal Dispute Resolution Process

FDA regulations provide a mechanism for those seeking regulatory approval of a drug product through a New Drug Application (NDA) to obtain formal review of any Agency decision through a Formal Dispute Resolution process by raising the matter with the supervisor of the employee who made the decision. If the issue is not resolved at the primary supervisory level, the applicant may request that the matter be reviewed at the next higher supervisory level. This process may continue through the Agency's chain of command, through the Centers to the Commissioner of Food and Drugs. The Formal Dispute Resolution process exists to encourage open, prompt discussion of scientific (including medical) disputes and procedural (including administrative) disputes that arise during the drug development, new drug review, generic drug review, and post-marketing oversight processes.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily fo
'/>"/>

SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
9. DaVita Receives Civil Complaint
10. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world ... be spotlighting its award-winning print and artwork inspection solutions, ScanProof and ArtProof ... 17 at the Olympia London, booth #F33 , Be the first to get a ...
(Date:9/3/2015)... ... , ... Hunters Creek Retrievers is again honored to salute America's ... Puppy. Celebrate Fall 2015 with unlimited Free Hugs and K9 Kisses from a premiere ... Christmas with an extra big smile. , This adorable trained Lab Pup is ...
(Date:9/3/2015)... ... September 03, 2015 , ... A scar is an unavoidable result of incision or ... of the body's ability to heal itself. The appearance of a scar is dependent on ... age, genes, and skin pigmentation. ”Many scars fade to near invisibility on their own over ...
(Date:9/3/2015)... MS (PRWEB) , ... September 03, 2015 , ... ... that their team will be participating at the highly anticipated Mississippi Gulf Babypalooza ... expectant mothers coming from all over, from Gulfport, Biloxi, and beyond. We will ...
(Date:9/3/2015)... Rosa, CA (PRWEB) , ... September 03, 2015 , ... About 220,800 new cases of ... One in seven men will be diagnosed with prostate cancer during their lifetime. While only ... to six of every 10 men by age 65, according to the American Cancer ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3
... increase in adult obesity rates in 31 states during the past ... fatal diseases such as// diabetes, stroke and cancer. ... efforts to curb the overweight epidemic, according to a new report ... titled F as in Fat: How Obesity Policies Are Failing America, ...
... Last year about 22,000 operations were cancelled by 34 hospitals ... to the report from these hospitals thousands of patients had ... be admitted to for elective surgery in 2005 had no ... in Dublin had to cancel 4,281 operations last year. Of ...
... shows that California is the fifth worst in the nation ... ,Texas was the worst with an uninsured ... was uninsured. Minnesota had the best record with only 8.7 ... ,New Mexico was noted to have an uninsured rate of ...
... healthcare problem, which has tickled the curiosity of researchers. To ... numbers of myths doing the rounds. To dispel the myths, ... from time to time. , ,A government ... obesity rates by 2010, where one in five girls between ...
... Papworth Hospital, Cambridge, in 1980 for cardiomyopathy died on Sunday ... heart transplant patient having survived for 26 years after undergoing ... diagnosed with cardiomyopathy and had a heart transplant last year. ... muscle becomes inflamed and does not work properly. ...
... specialists declared yesterday that coughing costs the UK economy ... of productivity when sufferers are not well costs approximately ... , ,According to the British Thoracic Society (BTS), ... asthma, drugs or environment factors. ,The BTS ...
Cached Medicine News:Health News:Rise in Obesity Rates in 31 States 2Health News:Rise in Obesity Rates in 31 States 3Health News:Cancellations of Operations touch 22,000 2
(Date:9/2/2015)... About implantable medical devices Implantable ... augment, or repair damaged tissues or organs. They ... including cosmetic, spinal, cardiovascular, ophthalmic, and neuro-stimulator implantation ... such as polymers, metals, ceramics, and biologics. ... market to grow at a CAGR of 8.54% ...
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... Forecasts Summary Advanced dressings have steadily ... treatment of a variety of wound indications, such ... fluid management, infection control, and physical protection become ... a greater role in standard therapy. This ...
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... is an X-linked disease, which generally affects the ... degeneration and weakness. The disease is caused due ... in the lack of production of dystrophin (a ... individuals. The lack of dystrophin weakens muscle function, ...
Breaking Medicine Technology:Global Implantable Medical Devices Market 2015-2019 2Advanced Wound Dressings - SA Analysis and Market Forecasts 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3
... -- MAP,Pharmaceuticals, Inc. today announced that it will ... clinical program at the 49th,Annual American Headache Society ... The poster presentation, which was,accepted as a late-breaker, ... of Inhaled Dihydroergotamine Mesylate,via a Novel Inhaler (Tempo(TM) ...
... Professor Home said: , "The editorials published by ... disregarded important pieces of data that,are extremely relevant ... data that showed no evidence,of any increase in ... Philip Home , CONTACT: Professor Philip Home, (44) ...
Cached Medicine Technology:MAP Pharmaceuticals to Present MAP0004 Phase 2 Clinical Data at the,American Headache Society Meeting 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: